Advaxis, Inc. (OTCQB:ADXS) (“Advaxis” or the “Company”), a leader in developing the next generation of immunotherapies for cancer and infectious diseases, announced that three abstracts describing research with Advaxis Lm-LLO immunotherapies have been selected for poster presentation at the Society for Immunotherapy of Cancer (SITC) 28th Annual Meeting, November 8-10, 2013 at the Gaylord National Hotel & Convention Center in National Harbor, MD.
Help employers find you! Check out all the jobs and post your resume.